tiprankstipranks
Trending News
More News >
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Compare Enliven Therapeutics (ELVN) vs. Competitors

Compare
319 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Enliven Therapeutics
$25.17
$1.55B
-13.64
11.08%
6 Buy
0 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$22.80
$2.39B
-82.14%
5 Buy
10 Hold
4 Sell
Hold
Viridian Therapeutics
$33.78
$3.22B
-9.35
89.94%
17 Buy
0 Hold
0 Sell
Strong Buy
Cidara Therapeutics
$221.38
$6.96B
-18.79
789.79%
Intellia Therapeutics
$12.02
$1.39B
-2.78
22.25%
9 Buy
12 Hold
1 Sell
Moderate Buy
AbCellera Biologics
$4.29
$1.28B
-7.25
41.22%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ELVN
Enliven Therapeutics
25.17
3.18
14.46%
SRPT
Sarepta Therapeutics
21.31
-95.75
-81.80%
VRDN
Viridian Therapeutics
33.03
15.97
93.61%
CDTX
Cidara Therapeutics
221.38
200.13
941.79%
NTLA
Intellia Therapeutics
11.87
2.45
26.01%
ABCL
AbCellera Biologics
4.18
1.24
42.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts